Citations (132)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Borui Yu, Mengqi Zhou, Zhaocheng Dong, Huijuan Zheng, Yuxue Zhao, Jingwei Zhou, Chao Zhang, Fudong Wei, Guoyong Yu, Wei Jing Liu, Hongfang Liu & Yaoxian Wang. (2023) Integrating network pharmacology and experimental validation to decipher the mechanism of the Chinese herbal prescription modified Shen-Yan-Fang-Shuai formula in treating diabetic nephropathy. Pharmaceutical Biology 61:1, pages 1222-1233.
Read now
Read now
Fan Wang, Chang Liu, LingZhi Ren, YanYang Li, HongMei Yang, Yang Yu & WeiPing Xu. (2023) Sanziguben polysaccharides improve diabetic nephropathy in mice by regulating gut microbiota to inhibit the TLR4/NF-κB/NLRP3 signalling pathway. Pharmaceutical Biology 61:1, pages 427-436.
Read now
Read now
Pengmin Ji, Qifeng Shi, Yan Liu, Min Han, Yong Su, Ran Sun, Huimin Zhou, Weizu Li & Weiping Li. (2023) Ginsenoside Rg1 treatment alleviates renal fibrosis by inhibiting the NOX4–MAPK pathway in T2DM mice. Renal Failure 45:1.
Read now
Read now
Wei Jiang, Kaixi Ding, Rensong Yue & Ming Lei. (2023) Therapeutic effects of icariin and icariside II on diabetes mellitus and its complications. Critical Reviews in Food Science and Nutrition 0:0, pages 1-26.
Read now
Read now
Heng-Cheng Lu, Wen-Ni Dai & Li-Yu He. (2021) Epigenetic Histone Modifications in the Pathogenesis of Diabetic Kidney Disease. Diabetes, Metabolic Syndrome and Obesity 14, pages 329-344.
Read now
Read now
Chhanda Charan Danta, Andrew N. Boa, Sunil Bhandari, Thozhukat Sathyapalan & Shang-Zhong Xu. (2021) Recent advances in drug discovery for diabetic kidney disease. Expert Opinion on Drug Discovery 16:4, pages 447-461.
Read now
Read now
Articles from other publishers (126)
Akeem Olalekan Lawal, Ibukun Mary Folorunso, Olufemi Adebisi, Omowumi Funmilayo Koledoye & Opeyemi Iwaloye. (2023) Morin hydrate promotes nephrin expression through modulation of Notch1-Snail signalling pathway in diabetic rats. Aspects of Molecular Medicine 2, pages 100019.
Crossref
Crossref
Yuto Saijo, Hiroshi Okada, Shinnosuke Hata, Hanako Nakajima, Nobuko Kitagawa, Takuro Okamura, Takafumi Osaka, Noriyuki Kitagawa, Saori Majima, Takafumi Senmaru, Emi Ushigome, Naoko Nakanishi, Masahide Hamaguchi & Michiaki Fukui. (2023) Reasons for Discontinuing Treatment with Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Diabetes in Real-World Settings: The KAMOGAWA-A Study. Journal of Clinical Medicine 12:22, pages 6993.
Crossref
Crossref
Huankai Yao, Ruoxi Zhao, Bangcheng Gu, Mengmeng Fu, Feng Yang, Yan Li & Changjiang Ying. (2023) Tiliroside from Potentilla chinensis attenuates oxidative stress and accumulation of ECM in mesangial cells under high glucose via activating Nrf2. Journal of Functional Foods 110, pages 105842.
Crossref
Crossref
Jinfeng Fu, Shiyun Tu, Ganjun Yi, Juan Wang, Ou Sheng & Wanying Zhang. (2023) Plantain flour – A beneficial material for the organ and transcriptional profile of kidney of diabetic rats. Journal of Functional Foods 110, pages 105817.
Crossref
Crossref
Chenguang Wu, Rui Zhang, Jingjing Wang, Yao Chen, Wenhui Zhu, Xiang Yi, Yan Wang, Lifan Wang, Peng Liu & Ping Li. (2023) Dioscorea nipponica Makino: A comprehensive review of its chemical composition and pharmacology on chronic kidney disease. Biomedicine & Pharmacotherapy 167, pages 115508.
Crossref
Crossref
Minjiang Huang, Yang Yang, Yuefu Chen, Yang Li, Sitao Qin, Lijun Xiao, Xuewen Long, Ke Hu, Yuxian Li, Huiming Ying & Yan Ding. (2023) Sweroside attenuates podocyte injury and proteinuria in part by activating Akt/BAD signaling in mice. Journal of Cellular Biochemistry 124:11, pages 1749-1763.
Crossref
Crossref
Liang Jin, Chao NiuYulong Ni. (2023) Correlation between peripheral blood α1-MG, DNMT1 expression, and the severity of diabetic nephropathy renal pathological damage. Medicine 102:42, pages e35409.
Crossref
Crossref
Lan Wei, Jingjing Gao, Liangzhi Wang, Qianru Tao & Chao Tu. (2023) Multi-omics analysis reveals the potential pathogenesis and therapeutic targets of diabetic kidney disease. Human Molecular Genetics.
Crossref
Crossref
Jintao Chen, Yajing Huang, Chuanfeng Liu, Jingwei Chi, Yangang Wang & Lili Xu. (2023) The role of C-peptide in diabetes and its complications: an updated review. Frontiers in Endocrinology 14.
Crossref
Crossref
Yi-hui Wang, Dong-yuan ChangMing-hui ZhaoMin Chen. (2023)
Dapagliflozin Alleviates Diabetic Kidney Disease
via
Hypoxia Inducible Factor 1α/Heme Oxygenase 1-Mediated Ferroptosis
. Antioxidants & Redox Signaling.
Crossref
Crossref
Marina Darenskaya, Sergey Kolesnikov, Natalya Semenova & Lyubov Kolesnikova. (2023) Diabetic Nephropathy: Significance of Determining Oxidative Stress and Opportunities for Antioxidant Therapies. International Journal of Molecular Sciences 24:15, pages 12378.
Crossref
Crossref
Aruna Rawat, Vikas Jhawat & Rohit Dutt. (2023) Nano Architect-Based Targeted Delivery Systems for Diabetic Nephropathy:
A Review. Current Drug Targets 24:8, pages 662-672.
Crossref
Crossref
Hongmei Yu, Mei Wang, Jingshi Yu, Haitao Tang, Qing Xu, Ning Cheng, Xiaoxiao Luo, Yurong Wang, Haitao Ge, Lei Qiang, Wei Tang & Harvest F. Gu. (2023) Evaluation of the efficacy of Abelmoschus manihot (L.) on diabetic nephropathy by analyzing biomarkers in the glomeruli and proximal and distal convoluted tubules of the kidneys. Frontiers in Pharmacology 14.
Crossref
Crossref
Heba R. Ghaiad, Shimaa O. Ali, Asmaa K. Al-Mokaddem & Maha Abdelmonem. (2023) Regulation of PKC/TLR-4/NF-kB signaling by sulbutiamine improves diabetic nephropathy in rats. Chemico-Biological Interactions 381, pages 110544.
Crossref
Crossref
Hui Zhao, Cheng-E Yang, Tian Liu, Ming-Xia Zhang, Yan Niu, Ming Wang & Jun Yu. (2023) The roles of gut microbiota and its metabolites in diabetic nephropathy. Frontiers in Microbiology 14.
Crossref
Crossref
Xiaodong Li, Xiaojuan Su, Fenglin Xia, Jing Qiu, Jiaqi Zhang, Haiyan Wu, Xuejun Xie & Mingchao Xu. (2023) Bibliometric and visual analysis of diabetes mellitus and pyroptosis from 2011 to 2022. European Journal of Medical Research 28:1.
Crossref
Crossref
Jianning Chen, Haiting Xiao, Rui Xue, Vinod Kumar, Rukhsana Aslam, Syed Faizan Mehdi, Huairong Luo, Ashwani Malhotra, Xiqian Lan & Pravin Singhal. (2023) Nicotine exacerbates diabetic nephropathy through upregulation of Grem1 expression. Molecular Medicine 29:1.
Crossref
Crossref
Zili Kong, Wenshan Lv, Yunyang Wang, Yajing Huang, Kui Che, Huiqi Nan, Yu Xin, Jiaxuan Wang, Jintao Chen, Yangang Wang & Jingwei Chi. (2023) Sinensetin ameliorates high glucose‐induced diabetic nephropathy via enhancing autophagy in vitro and in vivo. Journal of Biochemical and Molecular Toxicology.
Crossref
Crossref
Malik Çelik, Nezih Ziroğlu & Alkan Bayrak. (2023) Is Subcutaneous Rifamycin Application Superior to Saline Application in Hip Hemiarthroplasty?. Bakirkoy Tip Dergisi / Medical Journal of Bakirkoy 19:2, pages 186-190.
Crossref
Crossref
Xiaohong Xu, Zihan Qin, Ce Zhang, Xia Mi, Chi Zhang, Feihong Zhou, Junsheng Wang, Liexiang Zhang & Fei Hua. (2023) TRIM29 promotes podocyte pyroptosis in diabetic nephropathy through the NF‐kB/NLRP3 inflammasome pathway. Cell Biology International 47:6, pages 1126-1135.
Crossref
Crossref
Wenbo Yang, Xiaoli Li, Liujie He, Shuyang Zhu, Shicong Lai, Xiaopeng Zhang, Zixiong Huang, Biyue Yu, Chunping Cui & Qiang Wang. (2023) Empagliflozin improves renal ischemia–reperfusion injury by reducing inflammation and enhancing mitochondrial fusion through AMPK–OPA1 pathway promotion. Cellular & Molecular Biology Letters 28:1.
Crossref
Crossref
Maximilian J. Ganz, Katrin Bose, Carolin Herzog, S. Bender, Peter R. Mertens & Florian G. Scurt. (2023) Pathomechanismen der chronischen Nierenschädigung bei Diabetes und anderen BegleiterkrankungenPathomechanisms of chronic kidney injury in diabetes and other associated diseases. Die Diabetologie 19:3, pages 251-261.
Crossref
Crossref
Iuliia Azarova, Elena Klyosova & Alexey Polonikov. (2023) Single Nucleotide Polymorphisms of the RAC1 Gene as Novel Susceptibility Markers for Neuropathy and Microvascular Complications in Type 2 Diabetes. Biomedicines 11:3, pages 981.
Crossref
Crossref
Ze Wang, Jian Yuan, Wen-Bin Wan, Jie Ding, Lu Han, Pei Zhao, Kai Guo, Li Gao, Xia-Jun Zhou, De-Sheng Zhu & Yang-Tai Guan. (2023) Positive association between urinary albumin-creatinine ratio and lower extremity peripheral arterial disease in Chinese diabetes patients: A cross-section study with propensity score matching analysis. Nutrition, Metabolism and Cardiovascular Diseases 33:3, pages 541-550.
Crossref
Crossref
Zhonghui Cao, Xiao Gao, Jing Meng, Xiaoli Guo, Jiahao Xu, Junchao Cui & Xueyan Zhou. (2023) ACSL1: A preliminary study that provides a new target for the treatment of renal fibrosis could bring new insights in diabetic kidney disease. Nefrología.
Crossref
Crossref
Yanli Ma, Di Xie, Junchao Liu, Xinli Han, Hong Xu & Yu Chen. (2023) Angiopoietin-like protein 3 deficiency combined with valsartan administration protects better against podocyte damage in streptozotocin-induced diabetic nephropathy mice. International Immunopharmacology 115, pages 109715.
Crossref
Crossref
Shaokang Pan, Zhengyong Li, Yixue Wang, Lulu Liang, Fengxun Liu, Yingjin Qiao, Dongwei Liu & Zhangsuo Liu. (2023) A comprehensive weighted gene co-expression network analysis uncovers potential targets in diabetic kidney disease. Journal of Translational Internal Medicine 10:4, pages 359-368.
Crossref
Crossref
Aadhira Pillai & Darshna Fulmali. (2023) A Narrative Review of New Treatment Options for Diabetic Nephropathy. Cureus.
Crossref
Crossref
Xiyin Zheng, Lulu Yin, Jing Song, Juan Chen, Wensha Gu, Min Shi & Hong Zhang. (2023) ELABELA protects against diabetic kidney disease by activating high glucose-inhibited renal tubular autophagy. The Journal of Biomedical Research 37:6, pages 460.
Crossref
Crossref
Xiyin Zheng, Lulu Yin, Jing Song, Juan Chen, Wensha Gu, Min Shi & Hong Zhang. (2023) ELABELA protects against diabetic kidney disease by activating high glucose-inhibited renal tubular autophagy. The Journal of Biomedical Research 37:0, pages 1.
Crossref
Crossref
Mohammed H. Tawhari, Raed A. Aldahash, Faisal M. Almutairi, Mahdi S. Albogami, Ahmad E. Rokon, Faisal A. Alsomali, Khaled H. Alanazi, Abdulrahman A. Alshehri, Talal H. Almutairi, Abdulrahman D. Alharbi, Rayan M. Alghamdi, Ibrahim H. Tawhari & Salih A. Bin Salih. (2023) Impact of sodium-glucose cotransporter-2 inhibitors on kidney outcomes in type 2 diabetes: A tertiary center experience. Journal of Family and Community Medicine 30:4, pages 267-272.
Crossref
Crossref
央宗 才巴. (2023) Research Progress of FGF-21 and CVAI in Type 2 Diabetic Kidney Disease. Advances in Clinical Medicine 13:07, pages 12056-12061.
Crossref
Crossref
Jennifer Kelly & Richard Solomon. 2023. Diabetes and Cardiovascular Disease. Diabetes and Cardiovascular Disease
527
550
.
Gohar Sahakyan, Anne Vejux & Naira Sahakyan. (2022) The Role of Oxidative Stress-Mediated Inflammation in the Development of T2DM-Induced Diabetic Nephropathy: Possible Preventive Action of Tannins and Other Oligomeric Polyphenols. Molecules 27:24, pages 9035.
Crossref
Crossref
Alexis Hofherr, Julie Williams, Li-Ming Gan, Magnus Söderberg, Pernille B. L. Hansen & Kevin J. Woollard. (2022) Targeting inflammation for the treatment of Diabetic Kidney Disease: a five-compartment mechanistic model. BMC Nephrology 23:1.
Crossref
Crossref
Christine P. Limonte, Matthias Kretzler, Subramaniam Pennathur, Rodica Pop-Busui & Ian H. de Boer. (2022) Present and future directions in diabetic kidney disease. Journal of Diabetes and its Complications 36:12, pages 108357.
Crossref
Crossref
Yan Yang, Haiming Xiao, Zeyuan Lin, Rui Chen, Shanshan Li, Chuting Li, Xiaohong Sun, Ziqing Hei, Wenyan Gong & Heqing Huang. (2022) The ubiquitination of CKIP-1 mediated by Src aggravates diabetic renal fibrosis (original article). Biochemical Pharmacology 206, pages 115339.
Crossref
Crossref
Shaokang Pan, Zhengyong Li, Yixue Wang, Lulu Liang, Fengxun Liu, Yingjin Qiao, Dongwei Liu & Zhangsuo Liu. (2022) A comprehensive weighted gene co-expression network analysis uncovers potential targets in diabetic kidney disease. Journal of Translational Internal Medicine 0:0.
Crossref
Crossref
Pin-Jian Xiao, Jia-Cheng Zeng, Ping Lin, Dao-Bang Tang, En Yuan, Yong-Gang Tu, Qing-Feng Zhang, Ji-Guang Chen, Da-Yong Peng & Zhong-Ping Yin. (2022) Chalcone-1-Deoxynojirimycin Heterozygote Reduced the Blood Glucose Concentration and Alleviated the Adverse Symptoms and Intestinal Flora Disorder of Diabetes Mellitus Rats. Molecules 27:21, pages 7583.
Crossref
Crossref
Dan-Qian Chen, Jun Wu & Ping Li. (2022) Therapeutic mechanism and clinical application of Chinese herbal medicine against diabetic kidney disease. Frontiers in Pharmacology 13.
Crossref
Crossref
Yi-hui Wang, Dong-yuan Chang, Ming-hui Zhao & Min Chen. (2022) Glutathione Peroxidase 4 Is a Predictor of Diabetic Kidney Disease Progression in Type 2 Diabetes Mellitus. Oxidative Medicine and Cellular Longevity 2022, pages 1-10.
Crossref
Crossref
Chan-Young Jung & Tae-Hyun Yoo. (2022) Novel biomarkers for diabetic kidney disease. Kidney Research and Clinical Practice 41:Suppl 2, pages S46-S62.
Crossref
Crossref
Haiyan Cao, Xiaosheng Rao, Junya Jia, Tiekun Yan & Dong Li. (2022) Identification of tubulointerstitial genes and ceRNA networks involved in diabetic nephropathy via integrated bioinformatics approaches. Hereditas 159:1.
Crossref
Crossref
Jackie Trink, Renzhong Li, Evan Squire, Kian O’Neil, Phoebe Zheng, Bo Gao & Joan C. Krepinsky. (2022) Integrin β1/Cell Surface GRP78 Complex Regulates TGFβ1 and Its Profibrotic Effects in Response to High Glucose. Biomedicines 10:9, pages 2247.
Crossref
Crossref
Sevde Nur Fırat, Şerife Mehlika Kuşkonmaz, Muzaffer Çaydere, Mehmet Şeneş, Sema Hücümenoğlu & Cavit Çulha. (2022) Renoprotective effects of dapagliflozin in an iron overload non-diabetic rat model. Advances in Medical Sciences 67:2, pages 311-315.
Crossref
Crossref
Zengguang Kuang, Ningning Hou, Chengxia Kan, Fang Han, Hongyan Qiu & Xiaodong Sun. (2022) The protective effects of SGLT-2 inhibitors, GLP-1 receptor agonists, and RAAS blockers against renal injury in patients with type 2 diabetes. International Urology and Nephrology 55:3, pages 617-629.
Crossref
Crossref
Chunbo Niu, Lu Liu, Yang Li & Xiaoqi Li. (2022) Impact of Diabetic Nephropathy on Pulmonary Function and Clinical Outcomes. Computational Intelligence and Neuroscience 2022, pages 1-11.
Crossref
Crossref
Jiahao Chen, Qinhui Liu, Jinhan He & Yanping Li. (2022) Immune responses in diabetic nephropathy: Pathogenic mechanisms and therapeutic target. Frontiers in Immunology 13.
Crossref
Crossref
Minzhen Deng, Jingbo Sun, Lilin Peng, Yan Huang, Wen Jiang, Shuang Wu, Lihua Zhou, Sookja Kim Chung & Xiao Cheng. (2022) Scutellarin acts on the AR-NOX axis to remediate oxidative stress injury in a mouse model of cerebral ischemia/reperfusion injury. Phytomedicine 103, pages 154214.
Crossref
Crossref
Rui Ma, Ruomei Shao, Xuyao An, Qichun Zhang & Shuqing Sun. (2022) Recent advancements in noninvasive glucose monitoring and closed-loop management systems for diabetes. Journal of Materials Chemistry B 10:29, pages 5537-5555.
Crossref
Crossref
Daniel Jamrozik, Weronika Borymska & Ilona Kaczmarczyk-Żebrowska. (2022) Hibiscus sabdariffa in Diabetes Prevention and Treatment—Does It Work? An Evidence-Based Review. Foods 11:14, pages 2134.
Crossref
Crossref
Lingling Tian, Yi Wang, Jianbo Qing, Wenjing Zhou, Lin Sun, Rongshan Li & Yafeng Li. (2022)
A review of the pharmacological activities and protective effects of
Inonotus obliquus
triterpenoids in kidney diseases
. Open Chemistry 20:1, pages 651-665.
Crossref
Crossref
Guoshuang Zhu, Lan Wang, Zenan Wu, Mingliang Qiu, Shiwen Ke, Liangji Liu & Xiaoqin Wang. (2022) Renal Protective Mechanisms of Shenyuan Particle in Db/Db Mice: A Study Based on Network Pharmacology. Evidence-Based Complementary and Alternative Medicine 2022, pages 1-11.
Crossref
Crossref
Yi-Qi Yang, Hai-Bo Tan, Xiao-Yu Zhang, Yu-Zhen Zhang, Quan-You Lin, Min-Yi Huang, Zi-Yang Lin, Jia-Zhi Mo, Yue Zhang, Tian Lan, Wei-Jian Bei & Jiao Guo. (2022) The Chinese medicine Fufang Zhenzhu Tiaozhi capsule protects against renal injury and inflammation in mice with diabetic kidney disease. Journal of Ethnopharmacology 292, pages 115165.
Crossref
Crossref
Zhaohui Cao, Di Huang, Cifei Tang, Yang Lu, Shuangxiang Huang, Cuiying Peng & Xiaobo Hu. (2022) Pyroptosis in diabetes and diabetic nephropathy. Clinica Chimica Acta 531, pages 188-196.
Crossref
Crossref
Zhao Chen, Lifang Tian, Li Wang, Xiaotao Ma, Fuqian Lei, Xianghui Chen & Rongguo Fu. (2021) TRIM32 Inhibition Attenuates Apoptosis, Oxidative Stress, and Inflammatory Injury in Podocytes Induced by High Glucose by Modulating the Akt/GSK-3β/Nrf2 Pathway. Inflammation 45:3, pages 992-1006.
Crossref
Crossref
Xinyue Li, Butuo Xu, Jing Wu, Yueli Pu, Shengrong Wan, Yan Zeng, Mei Wang, Lifang Luo, Fanjie Zhang, Zongzhe Jiang & Yong Xu. (2022) Maresin 1 Alleviates Diabetic Kidney Disease via LGR6-Mediated cAMP-SOD2-ROS Pathway. Oxidative Medicine and Cellular Longevity 2022, pages 1-15.
Crossref
Crossref
Lei Liu, Fang Bai, Hui Song, Rong Xiao, Yuzhen Wang, Huimin Yang, Xiaolei Ren, Shuangjie Li, Lifen Gao, Chunhong Ma, Xiangdong Yang & Xiaohong Liang. (2022) Upregulation of TIPE1 in tubular epithelial cell aggravates diabetic nephropathy by disrupting PHB2 mediated mitophagy. Redox Biology 50, pages 102260.
Crossref
Crossref
Stephen A. Adefegha, Felix A. Dada, Sunday I. Oyeleye & Ganiyu Oboh. (2022) Effect of oral berberine administration on the renal profiles of adenosine deaminase, arginase, and nitric oxide in streptozotocin-induced diabetic nephropathy of rats. Comparative Clinical Pathology 31:2, pages 255-263.
Crossref
Crossref
Chan-Young Jung & Tae-Hyun Yoo. (2022) Pathophysiologic Mechanisms and Potential Biomarkers in Diabetic Kidney Disease. Diabetes & Metabolism Journal 46:2, pages 181-197.
Crossref
Crossref
Fabiola Carrara, Piero Ruggenenti, Annalisa Perna, Ilian Petrov Iliev, Flavio Gaspari, Silvia Ferrari, Nadia Stucchi, Antonio Bossi, Roberto Trevisan, Giuseppe Remuzzi & Aneliya Parvanova. (2021) Glomerular resistances predict long-term GFR decline in type 2 diabetic patients without overt nephropathy: a longitudinal subgroup analysis of the DEMAND trial. Acta Diabetologica 59:3, pages 309-317.
Crossref
Crossref
Shaoting Wang, Anna Zuo, Weiqiang Jiang, Jiarun Xie, Haoyu Lin, Wei Sun, Min Zhao, Jinjin Xia, Junqiao Shao, Xiaoshan Zhao, Donghui Liang, Aicheng Yang, Jia Sun & Ming Wang. (2022) JMJD1A/NR4A1 Signaling Regulates the Procession of Renal Tubular Epithelial Interstitial Fibrosis Induced by AGEs in HK-2. Frontiers in Medicine 8.
Crossref
Crossref
Sreenithya Ravindran & Shankar Munusamy. (2021) Renoprotective mechanisms of sodium‐glucose co‐transporter 2 (SGLT2) inhibitors against the progression of diabetic kidney disease. Journal of Cellular Physiology 237:2, pages 1182-1205.
Crossref
Crossref
Haru Nomura, Sanjaya Kuruppu & Niwanthi W. Rajapakse. (2022) Stimulation of Angiotensin Converting Enzyme 2: A Novel Treatment Strategy for Diabetic Nephropathy. Frontiers in Physiology 12.
Crossref
Crossref
Ying Wen, Yanyang Liu, Qi Huang, Rong Liu, Jing Liu, Fengyu Zhang, Shao Liu & Yueping Jiang. (2022) Moringa oleifera Lam. seed extract protects kidney function in rats with diabetic nephropathy by increasing GSK-3β activity and activating the Nrf2/HO-1 pathway. Phytomedicine 95, pages 153856.
Crossref
Crossref
Yujie Zhong, Ruilin Luo, Qi Liu, Jiachang Zhu, Min Lei, Xiaofei Liang, Xin Wang & Xiaoli Peng. (2022) Jujuboside A ameliorates high fat diet and streptozotocin induced diabetic nephropathy via suppressing oxidative stress, apoptosis, and enhancing autophagy. Food and Chemical Toxicology 159, pages 112697.
Crossref
Crossref
Chenxiao Liu, Qi Li, Xiu Feng, Jian Zhu & Qian Li. (2021) Deterioration of diabetic nephropathy via stimulating secretion of cytokines by atrial natriuretic peptide. BMC Endocrine Disorders 21:1.
Crossref
Crossref
Yi Wei & Zongpei Jiang. (2021) The evolution and future of diabetic kidney disease research: a bibliometric analysis. BMC Nephrology 22:1.
Crossref
Crossref
Yue Yu, Yuan-Yuan Jia, Meng Wang, Lin Mu & Hong-Jun Li. (2021) PTGER3 and MMP-2 play potential roles in diabetic nephropathy via competing endogenous RNA mechanisms. BMC Nephrology 22:1.
Crossref
Crossref
Manna Li, Le Deng & Gaosi Xu. (2021) METTL14 promotes glomerular endothelial cell injury and diabetic nephropathy via m6A modification of α-klotho. Molecular Medicine 27:1.
Crossref
Crossref
Frederik Persson, Morten Charles, Johan Vestergaard Povlsen & Søren Tang Knudsen. (2021) Improving frequency of urinary albumin testing in type 2 diabetes in primary care — An analysis of cross-sectional studies in Denmark. Primary Care Diabetes 15:6, pages 1007-1011.
Crossref
Crossref
Vemana Gowd, Jianbo Xiao, Mingfu Wang, Feng Chen & Ka‐Wing Cheng. (2021) Multi‐Mechanistic Antidiabetic Potential of Astaxanthin: An Update on Preclinical and Clinical Evidence. Molecular Nutrition & Food Research 65:24.
Crossref
Crossref
Zheling Feng, Zhujun Fang, Cheng Chen, Chi Teng Vong, Jiali Chen, Ruohan Lou, Maggie Pui Man Hoi, Lishe Gan & Ligen Lin. (2021) Anti-Hyperglycemic Effects of Refined Fractions from Cyclocarya paliurus Leaves on Streptozotocin-Induced Diabetic Mice. Molecules 26:22, pages 6886.
Crossref
Crossref
Remah Yassin*, Hagar Tadmor*, Evgeny Farber, Anas Igbariye, Aida Armaly-Nakhoul, Inbal Dahan, Farid Nakhoul & Nakhoul Nakhoul. (2021) Alteration of autophagy-related protein 5 (ATG5) levels and Atg5 gene expression in diabetes mellitus with and without complications. Diabetes and Vascular Disease Research 18:6, pages 147916412110620.
Crossref
Crossref
Md. Abdul Hye Khan, Sung Hee Hwang, Scott D. Barnett, Anna Stavniichuk, Wojciech K. Jankiewicz, Bruce D. Hammock & John D. Imig. (2021) Multitarget molecule, PTUPB, to treat diabetic nephropathy in rats. British Journal of Pharmacology 178:22, pages 4468-4484.
Crossref
Crossref
Yuyuan LiuLing ZhangYanzhe WangLinnan BaiSijia ChenJing YangXiaoxia Wang. (2021) Exploring the Role of CircRNA in Diabetic Kidney Disease from a Novel Perspective: Focusing on Both Glomeruli and Tubuli. DNA and Cell Biology 40:11, pages 1369-1380.
Crossref
Crossref
Fengxia Zhang, Nan Jiang, Yan Gao, Zuyan Fan, Quhuan Li, Guibao Ke, Bohou Li, Qiong Wu, Ruiquan Xu & Shuangxin Liu. (2021) PPBP as a marker of diabetic nephropathy podocyte injury via Bioinformatics Analysis. Biochemical and Biophysical Research Communications 577, pages 165-172.
Crossref
Crossref
Juan A. Parga, Ana I. Rodriguez-Perez, Maria Garcia-Garrote, Jannette Rodriguez-Pallares & Jose L. Labandeira-Garcia. (2021) NRF2 Activation and Downstream Effects: Focus on Parkinson’s Disease and Brain Angiotensin. Antioxidants 10:11, pages 1649.
Crossref
Crossref
Chuin Ying Ung, Alexandros Onoufriadis, Maddy Parsons, John A. McGrath & Tanya J. Shaw. (2021) Metabolic perturbations in fibrosis disease. The International Journal of Biochemistry & Cell Biology 139, pages 106073.
Crossref
Crossref
Sonia Mota-Zamorano, Nicolás R. Robles, Luz M. González, José M. Valdivielso, Juan Lopez-Gomez, Bárbara Cancho, Guadalupe García-Pino & Guillermo Gervasini. (2021) Genetics Variants in the Epoxygenase Pathway of Arachidonic Metabolism Are Associated with Eicosanoids Levels and the Risk of Diabetic Nephropathy. Journal of Clinical Medicine 10:17, pages 3980.
Crossref
Crossref
Ayobami Dare, Mahendra L. Channa & Anand Nadar. (2021) L-ergothioneine and its combination with metformin attenuates renal dysfunction in type-2 diabetic rat model by activating Nrf2 antioxidant pathway. Biomedicine & Pharmacotherapy 141, pages 111921.
Crossref
Crossref
Junmin Wang, Hongjiao Xiang, Yifei Lu, Tao Wu & Guang Ji. (2021) New progress in drugs treatment of diabetic kidney disease. Biomedicine & Pharmacotherapy 141, pages 111918.
Crossref
Crossref
Gao‐shu Zheng, Yan‐min Tan, Yuan‐yuan Shang, Ya‐peng Liu, Bo‐ang Hu, Di Wang, Lu Han, Zhi‐hao Wang, Wei Zhang, Yun Ti & Ming Zhong. (2021) CIDEC silencing attenuates diabetic nephropathy via inhibiting apoptosis and promoting autophagy. Journal of Diabetes Investigation 12:8, pages 1336-1345.
Crossref
Crossref
Zhirong Jia, Kaiwei Wang, Yameng Zhang, Yalei Duan, Kang Xiao, Shuo Liu & Xuansheng Ding. (2021) Icariin Ameliorates Diabetic Renal Tubulointerstitial Fibrosis by Restoring Autophagy via Regulation of the miR-192-5p/GLP-1R Pathway. Frontiers in Pharmacology 12.
Crossref
Crossref
Qi Li, Delma Veron & Alda Tufro. (2021) S-Nitrosylation of RhoGAP Myosin9A Is Altered in Advanced Diabetic Kidney Disease. Frontiers in Medicine 8.
Crossref
Crossref
Ying Wang, Jiang Chang, Zi-Qiang Wang & Ying Li. (2021) Sirt3 promotes the autophagy of HK‑2 human proximal tubular epithelial cells via the inhibition of Notch‑1/Hes‑1 signaling. Molecular Medicine Reports 24:3.
Crossref
Crossref
Devang M. Patel, Yuxin Yang, Kexin Shi, Tieqiao Wu, Mark E. Cooper & Zhonglin Chai. (2021) Key profibrotic and pro-inflammatory pathways in the pathogenesis of diabetic kidney disease. Diabetic Nephropathy 1:1, pages 15-26.
Crossref
Crossref
Pappitha Raja, Alexander P. Maxwell & Derek P. Brazil. (2020) The Potential of Albuminuria as a Biomarker of Diabetic Complications. Cardiovascular Drugs and Therapy 35:3, pages 455-466.
Crossref
Crossref
Pantelis Sarafidis, Christodoulos E. Papadopoulos, Vasilios KamperidisGeorge Giannakoulas & Michael Doumas. (2021) Cardiovascular Protection With Sodium-Glucose Cotransporter-2 Inhibitors and Mineralocorticoid Receptor Antagonists in Chronic Kidney Disease. Hypertension 77:5, pages 1442-1455.
Crossref
Crossref
Anastasiia Sholokh & Enno Klussmann. (2021) Local cyclic adenosine monophosphate signalling cascades—Roles and targets in chronic kidney disease. Acta Physiologica 232:1.
Crossref
Crossref
Ralph A. DeFronzo, W. Brian Reeves & Alaa S. Awad. (2021) Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors. Nature Reviews Nephrology 17:5, pages 319-334.
Crossref
Crossref
LinLin Chen, Jiao Wu, Bin Hu, Changbai Liu & Hu Wang. (2021) The Role of Cell Division Autoantigen 1 (CDA1) in Renal Fibrosis of Diabetic Nephropathy. BioMed Research International 2021, pages 1-13.
Crossref
Crossref
Mingyang Hu, Jiuyuan Fang, Huijuan Wang & Sijie Zhou. (2021) Proteome and Phosphoproteome Analyses Reveal the Kinase Regulatory Network Involved in Glycogen Synthesis Kinase 3β. Frontiers in Genetics 12.
Crossref
Crossref
Nimeet Desai, HariPriya Koppisetti, Shreya Pande, Havish Shukla, Bhagwat Sirsat, Aayushi S Ditani, Pragyan P Mallick, Umesh Kathar, Kiran Kalia & Rakesh K Tekade. (2021) Nanomedicine in the treatment of diabetic nephropathy. Future Medicinal Chemistry 13:7, pages 663-686.
Crossref
Crossref
Shuang-Shuang Zheng, Yue-Ming He & Jie Lu. (2020) Noninvasive evaluation of diabetic patients with high fasting blood glucose using DWI and BOLD MRI. Abdominal Radiology 46:4, pages 1659-1669.
Crossref
Crossref
Asfia Soomro, Jackie Trink, Kian O’Neil, Renzhong Li, Safaa Naiel, Bo Gao, Kjetil Ask & Joan C. Krepinsky. (2021) Activin A and Cell-Surface GRP78 Are Novel Targetable RhoA Activators for Diabetic Kidney Disease. International Journal of Molecular Sciences 22:6, pages 2839.
Crossref
Crossref
Jose Augusto Nogueira-Machado, Gabriela Rossi Ferreira, Caroline Maria Oliveira Volpe, Pedro Henrique Villar-Delfino & Fabiana Rocha Silva. (2021) Diabetes potentiates ROS production in granulocytes from patients with chronic kidney disease. Endocrinology&Metabolism International Journal 9:1, pages 9-14.
Crossref
Crossref
Yaping Xiao, Jianling Deng, Chunming Li, Xiaobao Gong, Zhenwei Gui, Jieyao Huang, Yaru Zhang, Yan Liu, Xiaoli Ye & Xuegang Li. (2021) Epiberberine ameliorated diabetic nephropathy by inactivating the angiotensinogen (Agt) to repress TGFβ/Smad2 pathway. Phytomedicine 83, pages 153488.
Crossref
Crossref
K. V. Skobeleva & L. V. Tyrtova. (2021) The effect of the components of the renin-angiotensinaldosterone system on the development of diabetic nephropathy in type 1 diabetes (review). Nephrology (Saint-Petersburg) 25:2, pages 43-51.
Crossref
Crossref
Dan Zhao, Xiaoyu Zhu, Lili Jiang, Xiu Huang, Yangyang Zhang, Xuejiao Wei, Xiaoxia Zhao & Yujun Du. (2020) Advances in understanding the role of adiponectin in renal fibrosis. Nephrology 26:2, pages 197-203.
Crossref
Crossref
Xia Gu, Yi Liu, Na Wang, Junhui Zhen, Bo Zhang, Shaoshuai Hou, Zhengguo Cui, Qiang Wan & Hong Feng. (2021) Transcription of MRPL12 regulated by Nrf2 contributes to the mitochondrial dysfunction in diabetic kidney disease. Free Radical Biology and Medicine 164, pages 329-340.
Crossref
Crossref
Ning-Ning Hou, Cheng-Xia Kan, Na Huang, Yong-Ping Liu, En-Wen Mao, Yu-Ting Ma, Fang Han, Hong-Xi Sun & Xiao-Dong Sun. (2021) Relationship between serum Dickkopf-1 and albuminuria in patients with type 2 diabetes. World Journal of Diabetes 12:1, pages 47-55.
Crossref
Crossref
Ying Wang, Xuefeng Zhou, Minjing Luo, Tingting Zhao & Ping Li. (2021) Xiaochaihu Decoction in Diabetic Kidney Disease: A Study based on Network Pharmacology and Molecular Docking Technology. Integrative Medicine in Nephrology and Andrology 8:1, pages 13.
Crossref
Crossref
Belgin Sever, Mehlika Dilek Altıntop, Yeliz Demir, Muhammed Pekdoğan, Gülşen Akalın Çiftçi, Şükrü Beydemir & Ahmet Özdemir. (2021) An extensive research on aldose reductase inhibitory effects of new 4H-1,2,4-triazole derivatives. Journal of Molecular Structure 1224, pages 129446.
Crossref
Crossref
Jia Wang & Su-Mei Zhao. (2021) LncRNA-antisense non-coding RNA in the INK4 locus promotes pyroptosis via miR-497/thioredoxin-interacting protein axis in diabetic nephropathy. Life Sciences 264, pages 118728.
Crossref
Crossref
Jozaa Z. ALTamimi, Nora A. AlFaris, Ammar M. AL-Farga, Ghedeir M. Alshammari, Mona N. BinMowyna & Mohammed A. Yahya. (2021) Curcumin reverses diabetic nephropathy in streptozotocin-induced diabetes in rats by inhibition of PKCβ/p66Shc axis and activation of FOXO-3a. The Journal of Nutritional Biochemistry 87, pages 108515.
Crossref
Crossref
Mahmoud E. Youssef, Heba M. Abdelrazek & Yasser M. Moustafa. (2020) Cardioprotective role of GTS-21 by attenuating the TLR4/NF-κB pathway in streptozotocin-induced diabetic cardiomyopathy in rats. Naunyn-Schmiedeberg's Archives of Pharmacology 394:1, pages 11-31.
Crossref
Crossref
Habib Yaribeygi, Mina Maleki, Muhammed Majeed, Tannaz Jamialahmadi & Amirhossein Sahebkar. 2021. Natural Products and Human Diseases. Natural Products and Human Diseases
531
544
.
Rui Wu, Fan Wei, Lianlian Qu, Litao Bai, Jun Li, Fei Li, Weitian Yan, Qiuhong Wang & Junping Wei. (2020) Effects of Keluoxin capsule combined with losartan potassium on diabetic kidney disease: study protocol for a randomized double-blind placebo-controlled multicenter clinical trial. Trials 21:1.
Crossref
Crossref
Yusong Nie, Chengxiao Fu, Huimin Zhang, Min Zhang, Hui Xie, Xiaopei Tong, Yao Li, Zhenyan Hou, Xinrong Fan & Miao Yan. (2020) Celastrol slows the progression of early diabetic nephropathy in rats via the PI3K/AKT pathway. BMC Complementary Medicine and Therapies 20:1.
Crossref
Crossref
Kehinde Sulaimon Ayinde, Olamide Tosin Olaoba, Boyenle Ibrahim, Du Lei, Qian Lu, Xiaoxing Yin & Temitope Isaac Adelusi. (2020) AMPK allostery: A therapeutic target for the management/treatment of diabetic nephropathy. Life Sciences 261, pages 118455.
Crossref
Crossref
Ying Wang, Mei Han, Christopher E. Pedigo, Nanqi Zhao & Jian-Ping Liu. (2020) Combination of Oral Tripterygium Glycosides and angiotensin II receptor blockers for treatment of clinical stage diabetic kidney disease: A systematic review and meta-analysis of randomized controlled trials. European Journal of Integrative Medicine 39, pages 101197.
Crossref
Crossref
M. Loredana Marcovecchio. (2020) Importance of Identifying Novel Biomarkers of Microvascular Damage in Type 1 Diabetes. Molecular Diagnosis & Therapy 24:5, pages 507-515.
Crossref
Crossref
Ling Chen, Binbin Wu, Shaobin Wang, Yu Xiong, Boya Zhou, Xianyi Cheng, Tao Zhou, Ruibang Luo, Tak-Wah Lam, Bin Yan & Junhui Chen. (2020) Identification of Cooperative Gene Regulation Among Transcription Factors, LncRNAs, and MicroRNAs in Diabetic Nephropathy Progression. Frontiers in Genetics 11.
Crossref
Crossref
Elias A. T. Koch, Rola Nakhoul, Farid Nakhoul & Nakhoul Nakhoul. (2020) Autophagy in diabetic nephropathy: a review. International Urology and Nephrology 52:9, pages 1705-1712.
Crossref
Crossref
Swetha R. Kanduri, Karthik Kovvuru, Panupong Hansrivijit, Charat Thongprayoon, Saraschandra Vallabhajosyula, Aleksandra I. Pivovarova, Api Chewcharat, Vishnu Garla, Juan Medaura & Wisit Cheungpasitporn. (2020) SGLT2 Inhibitors and Kidney Outcomes in Patients with Chronic Kidney Disease. Journal of Clinical Medicine 9:9, pages 2723.
Crossref
Crossref
Hui Juan Zheng, Xueqin Zhang, Jing Guo, Wenting Zhang, Sinan Ai, Fan Zhang, Yaoxian Wang & Wei Jing Liu. (2020) Lysosomal dysfunction–induced autophagic stress in diabetic kidney disease. Journal of Cellular and Molecular Medicine 24:15, pages 8276-8290.
Crossref
Crossref
Ricardo Vitor Cohen, Tiago Veiga Pereira, Cristina Mamédio Aboud, Tarissa Beatrice Zanata Petry, José Luis Lopes Correa, Carlos Aurélio Schiavon, Carlos Eduardo Pompílio, Fernando Nogueira Quirino Pechy, Ana Carolina Calmon da Costa Silva, Fernanda Lendimuth Gomes de Melo, Lívia Porto Cunha da Silveira, Pedro Paulo de Paris Caravatto, Helio Halpern, Frederico de Lima Jacy Monteiro, Bruno da Costa Martins, Rogerio Kuga, Thais Mantovani Sarian Palumbo, Neil Gerard Docherty & Carel Wynand le Roux. (2020) Effect of Gastric Bypass vs Best Medical Treatment on Early-Stage Chronic Kidney Disease in Patients With Type 2 Diabetes and Obesity. JAMA Surgery 155:8, pages e200420.
Crossref
Crossref
Yong Yang, Yong Wang, Zuowen He, Yunchang Liu, Chen Chen, Yan Wang, Dao Wen Wang & Hong Wang. (2020) Trimetazidine Inhibits Renal Tubular Epithelial Cells to Mesenchymal Transition in Diabetic Rats via Upregulation of Sirt1. Frontiers in Pharmacology 11.
Crossref
Crossref
Yuliya Lytvyn, Petter Bjornstad, Daniel H van Raalte, Hiddo L Heerspink & David Z I Cherney. (2020) The New Biology of Diabetic Kidney Disease—Mechanisms and Therapeutic Implications. Endocrine Reviews 41:2, pages 202-231.
Crossref
Crossref
Zhixia Song, Jiefu Zhu, Qingqing Wei, Guie Dong & Zheng Dong. (2020) Canagliflozin reduces cisplatin uptake and activates Akt to protect against cisplatin-induced nephrotoxicity. American Journal of Physiology-Renal Physiology 318:4, pages F1041-F1052.
Crossref
Crossref
Jonatan Barrera‐Chimal & Frédéric Jaisser. (2020) Pathophysiologic mechanisms in diabetic kidney disease: A focus on current and future therapeutic targets. Diabetes, Obesity and Metabolism 22:S1, pages 16-31.
Crossref
Crossref
Søren T. Knudsen & Mark E. Cooper. (2020) Renal protection: What have we learnt from ADVANCE about kidney disease in type 2 diabetes?. Diabetes, Obesity and Metabolism 22:S2, pages 12-18.
Crossref
Crossref
Devang M. Patel, Madhura Bose & Mark E. Cooper. (2020) Glucose and Blood Pressure-Dependent Pathways–The Progression of Diabetic Kidney Disease. International Journal of Molecular Sciences 21:6, pages 2218.
Crossref
Crossref
Wenting Liu, Xiaowen Chen, Yuxian Wang, Yihua Chen, Sijia Chen, Wangqiu Gong, Ting Chen, Lingzhi Sun, Chenghao Zheng, Bohui Yin, Shuting Li, Congwei Luo, Qianyin Huang, Jing Xiao, Zhaozhong Xu, Fenfen Peng & Haibo Long. (2019) Micheliolide ameliorates diabetic kidney disease by inhibiting Mtdh-mediated renal inflammation in type 2 diabetic db/db mice. Pharmacological Research 150, pages 104506.
Crossref
Crossref
Dong Zhou, Haiyan Fu, Yang Han, Lu Zhang, Shijia Liu, Lin Lin, Donna B. Stolz & Youhua Liu. (2019) Sonic hedgehog connects podocyte injury to mesangial activation and glomerulosclerosis. JCI Insight 4:22.
Crossref
Crossref